Stay updated on Volitinib for Primary CNS Tumors Clinical Trial

Sign up to get notified when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Volitinib for Primary CNS Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Removal of the government funding status notice from the page; core study information such as eligibility criteria, interventions, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:49:46.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    48 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a new version tag v3.2.0; removed the previous version tag v3.1.0. Overall, a significant update to status messaging and versioning.
    Difference
    2%
    Check dated 2025-10-06T05:33:06.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.0%
    Check dated 2025-09-29T03:05:40.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the Back to Top link was removed.
    Difference
    0.1%
    Check dated 2025-09-14T19:11:47.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T15:25:44.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location details, as well as additional resources related to genetic and rare diseases, while removing outdated location terms and certain disease attributes.
    Difference
    3%
    Check dated 2025-08-31T11:54:13.000Z thumbnail image

Stay in the know with updates to Volitinib for Primary CNS Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.